NKMax America is harnessing the power of the body's immune system through the development of unique Natural Killer (NK) cell therapies. NK cell adoptive immunotherapy enhances a patient's ability to destroy abnormal cells.
TeamView all (15)
Chief Scientific Officer, Chief Innovation Officer
Will de Groot
Chief Business Officer
Director, Clinical Laboratory Operations
Assistant Director, Manufacturing